A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

NCT06346600 · clinicaltrials.gov ↗

RECRUITING

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular (Wet) Age-related Macular Degeneration

Interventions

GENETIC: SKG0106

Sponsor

Skyline Therapeutics